Literature DB >> 8636352

The influence of polydipsia on water excretion in hyponatremic, polydipsic, schizophrenic patients.

M B Goldman1, G L Robertson, D J Luchins, D Hedeker.   

Abstract

To determine whether polydipsia is responsible for the altered water excretion in the subset of polydipsic schizophrenic patients who develop hyponatremia, the regulation of antidiuretic function was assessed in polydipsic schizophrenic patients with hyponatremia (n = 5), polydipsic schizophrenic patients without hyponatremia (n = 5), nonpolydipsic schizophrenic patients (n = 6), and normal controls (n = 8). The severity and duration of polyuria were similar in the two polydipsic groups. After oral water loading, maximal free water clearance was similar across all four groups. Free water clearance diminished, however, at lower plasma osmolalities in the hyponatremic polydipsics (P < 0.02) and at higher plasma osmolalities in the normonatremic polydipsics (P < 0.05) relative to that in the nonpolydipsic schizophrenics and normal subjects. The increase in plasma vasopressin after osmotic stimulation with hypertonic saline was slightly, but significantly (P < 0.02), blunted in both polydipsic groups. Hyponatremia occurs in some polydipsic schizophrenics because the relationship between free water clearance to plasma osmolality/sodium is shifted to the left. Polydipsia per se is not responsible for this still unexplained shift.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636352     DOI: 10.1210/jcem.81.4.8636352

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  16 in total

1.  Effects of hydration and hyperventilation on cortical complexity.

Authors:  Viktor Müller; Niels Birbaumer; Hubert Preissl; Christoph Braun; Gottfried Mayer-Kress; Florian Lang
Journal:  Exp Brain Res       Date:  2003-04-16       Impact factor: 1.972

2.  Structural pathology underlying neuroendocrine dysfunction in schizophrenia.

Authors:  Morris B Goldman; Lei Wang; Carly Wachi; Sheeraz Daudi; John Csernansky; Megan Marlow-O'Connor; Sarah Keedy; Ivan Torres
Journal:  Behav Brain Res       Date:  2010-11-17       Impact factor: 3.332

3.  A lethal complication of psychogenic polydipsia: cerebral edema and herniation.

Authors:  J J Ligtenberg; A N Wymenga; J E Tulleken; T S van der Werf; J G Zijlstra
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

4.  Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study.

Authors:  Hang-Ju Yang; Wan-Ju Cheng
Journal:  Psychopharmacology (Berl)       Date:  2017-01-11       Impact factor: 4.530

Review 5.  Primary polydipsia: Update.

Authors:  Leeda Ahmadi; Morris B Goldman
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-10-14       Impact factor: 4.690

6.  Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.

Authors:  Cyndie K Mannesse; Eugène P van Puijenbroek; Paul A F Jansen; Rob J van Marum; Patrick C Souverein; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

Review 7.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 8.  Brain circuit dysfunction in a distinct subset of chronic psychotic patients.

Authors:  Morris B Goldman
Journal:  Schizophr Res       Date:  2014-07-01       Impact factor: 4.939

9.  Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits.

Authors:  Morris Goldman; Megan Marlow-O'Connor; Ivan Torres; C S Carter
Journal:  Schizophr Res       Date:  2007-10-24       Impact factor: 4.939

Review 10.  Psychogenic polydipsia review: etiology, differential, and treatment.

Authors:  Brian Dundas; Melissa Harris; Meera Narasimhan
Journal:  Curr Psychiatry Rep       Date:  2007-06       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.